The benefits of long-term peritoneal dialysis (PD) in patients with end-stage renal failure are
short-lived due to structural and functional changes in the peritoneal membrane. In this …

Peritoneal fibrosis is an important complication of peritoneal dialysis (PD). To investigate
and address this problem, an appropriate animal model of PD is required. The present …

Background. Long-term peritoneal dialysis (PD) is associated with the development of
functional and structural alterations of the peritoneal membrane. In this study, we …

Peritoneal dialysis (PD) is associated with functional and structural changes of the
peritoneal membrane, also known as peritoneal remodeling. The peritoneal membrane is …

Background A long-term peritoneal exposure model has been developed in Wistar rats.
Chronic daily exposure to 3.86% glucose based, lactate buffered, conventional dialysis …

Reactive oxygen species amplify protein kinase C signaling in high glucose-induced
fibronectin expression by human peritoneal mesothelial cells. Background We previously …

Aim C‐reactive protein (CRP) is a mediator of systemic inflammation. Peritoneal dialysis
(PD) is known to cause peritoneal inflammation and fibrosis. We compare the degree of …

Background Noninfectious upregulation of proinflammatory pathways in mesothelial cells
may represent an integral part of their stress response upon exposure to peritoneal dialysis …

Peritoneal fibrosis is a severe complication arising from long-term peritoneal dialysis (PD).
Tamoxifen (Tamo) has been clinically proven effective in a series of fibrotic diseases, such …

Human peritoneal mesothelial cells (HMC) contribute to the activation and control of
inflammatory processes in the peritoneum by their potential to produce various inflammatory …